XML 34 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2012
Stock-Based Compensation [Abstract]  
Assumption of stock option's fair value
                                 
    Three Months Ended     Six Months Ended  
    June 30,
2012
    July 2,
2011
    June 30,
2012
    July 2,
2011
 

Stock Options

                               

Expected life

    4.2 years       4.5 years       4.5 years       4.5 years  

Volatility

    78.65     77.49     78.23     76.97

Risk free interest rate

    0.74     1.84     0.85     2.00

Dividends

    0       0       0       0  

Employee Stock Purchase Plan

                               

Expected life

    0.5 years       0.5 years       0.5 years       0.5 years  

Volatility

    55.93     68.27     62.74     76.20

Risk free interest rate

    0.06     0.21     0.06     0.20

Dividends

    0       0       0       0  
Stock option plans activity
                                 
    Number of
Shares
Outstanding
(Options)
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Contractual Term
(Years)
    Aggregate
Intrinsic Value (in
Thousands)
 

Options

                               

Outstanding at December 31, 2011

    2,348,162     $ 10.53       4.86     $ 18,556  

Exercised

    (281,450     6.32                  

Granted

    200,485       17.72                  

Cancelled

    (49,843     14.53                  
   

 

 

   

 

 

                 

Outstanding at June 30, 2012

    2,217,354     $ 11.62       4.69     $ 9,587  
   

 

 

   

 

 

   

 

 

   

 

 

 

Exercisable at June 30, 2012

    1,206,793     $ 9.14       4.00     $ 7,781  
   

 

 

   

 

 

   

 

 

   

 

 

 
Stock-based compensation expense for all share-based payment awards
                                 
    Three Months Ended     Six Months Ended  
    June 30,
2012
    July 2,
2011
    June 30,
2012
    July 2,
2011
 

Cost of products

  $ 20     $ 28     $ 77     $ 66  

Cost of service

    75       43       133       95  

Research and development

    347       221       666       368  

Selling

    481       311       922       526  

General and administrative

    670       352       1,256       722  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total stock-based compensation expense

  $ 1,593     $ 955     $ 3,054     $ 1,777